FDA Withdraws Thyroid Medication from Market for Being Less Effective
· Telemundo McAllen (KTLM)
The U.S. Food and Drug Administration (FDA) has withdrawn a commonly prescribed thyroid medication from the market. The recall affects levothyroxine sodium tablets, which are used to treat hypothyroidism and reduce the size of the thyroid gland when it is enlarged, according to the Mayo Clinic. The FDA reported that the medications were functioning as lower potency products than indicated, meaning they contained a lesser amount of the active ingredient and were therefore less effective. The recalled tablets were packaged and distributed by Major Pharmaceuticals. Cardinal Health also distributed some of the affected products.
AI summary · Source: Telemundo McAllen (KTLM) →
